Ascletis Pharma Inc. Reports Preclinical Weight-Loss Results for Two Candidates
Ascletis reported preclinical results for ASC30_48 FDC, which reduced monkey body weight 10.5% by Day 9 versus 6.9% with ASC30 alone, and ASC37, which reduced DIO mouse body weight up to 41.5% by Day 12. No prior-period comparison was provided.Material DetailsContext by AI AnalystThese are early-st…